Verax Biomedical Inc-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Verax Biomedical Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8011871
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月13日
◆ページ数:17
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Verax Biomedical Inc (Verax) is a medical device company that develops rapid tests for the detection of bacterial contaminants in tissues for transplantation, blood components, and cellular therapies. The company’s products comprise platelet pgd test, red cell pgd test and cell therapy PGD test. It uses the PGD technology to conduct its tests. Verax’s product platelet pgd test is used for the detection of bacterial contamination in platelets. It uses Pan Genera Detection technology to develop tests in order to detect the bacteria in blood components. The company operates through its laboratory facility located in Marlborough. Verax is headquartered in Marlborough, Massachusetts, the US.

Verax Biomedical Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Verax Biomedical Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Verax Biomedical Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Verax Biomedical Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Verax Biomedical Inc, Medical Devices Deals, 2011 to YTD 2017 8
Verax Biomedical Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Verax Biomedical Inc, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Verax Biomedical Raises USD11.4 Million in Venture Financing 10
Verax Biomedical Raises USD12.6 Million in Venture Financing 11
Verax Biomedical Raises USD4 Million in Venture Financing 12
Verax Biomedical Inc – Key Competitors 13
Verax Biomedical Inc – Key Employees 14
Verax Biomedical Inc – Locations And Subsidiaries 15
Head Office 15
Recent Developments 16
Corporate Communications 16
Feb 22, 2016: Verax Biomedical announces appointment of Paul D. Mintz, M.D. as Senior Vice President and Chief Medical Officer 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List of Tables
Verax Biomedical Inc, Pharmaceuticals & Healthcare, Key Facts 2
Verax Biomedical Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 2
Verax Biomedical Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Verax Biomedical Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Verax Biomedical Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Verax Biomedical Inc, Medical Devices Deals, 2011 to YTD 2017 8
Verax Biomedical Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Verax Biomedical Raises USD11.4 Million in Venture Financing 10
Verax Biomedical Raises USD12.6 Million in Venture Financing 11
Verax Biomedical Raises USD4 Million in Venture Financing 12
Verax Biomedical Inc, Key Competitors 13
Verax Biomedical Inc, Key Employees 14

★海外企業調査レポート[Verax Biomedical Inc-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Linamar Corporation (LNR):企業の財務・戦略的SWOT分析
    Linamar Corporation (LNR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • OneMain Holdings Inc:企業の戦略・SWOT・財務分析
    OneMain Holdings Inc - Strategy, SWOT and Corporate Finance Report Summary OneMain Holdings Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Nuverra Environmental Solutions Inc (NES):企業の財務・戦略的SWOT分析
    Nuverra Environmental Solutions Inc (NES) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strength …
  • OncoSec Medical Inc (ONCS):製薬・医療:M&Aディール及び事業提携情報
    Summary OncoSec Medical Inc (OncoSec) is a biotechnology company that offers services to stimulate body’s immune system and attack cancer. It’s lead candidate, ImmunoPulse IL-12, consists of a plasmid construct encoding the proinflammatory cytokine, IL-12, which is delivered into the tumor through i …
  • Cooperative Energy:企業の戦略的SWOT分析
    Cooperative Energy - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • HeidelbergCement AG:戦略・SWOT・企業財務分析
    HeidelbergCement AG - Strategy, SWOT and Corporate Finance Report Summary HeidelbergCement AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Rezolute Inc (RZLT):製薬・医療:M&Aディール及び事業提携情報
    Summary Rezolute Inc (Rezolute) formerly known as AntriaBio Inc, is a clinical stage biopharmaceutical company specializing in the development of innovative drug therapies for the treatment of metabolic and orphan diseases. Its pipeline product portfolio includes AB101, a microsphere formulation of …
  • Sany Heavy Industry Co Ltd (600031):企業の財務・戦略的SWOT分析
    Sany Heavy Industry Co Ltd (600031) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Aselsan Elektronik Sanayi Ve Ticaret A.S.:企業の戦略・SWOT・財務情報
    Aselsan Elektronik Sanayi Ve Ticaret A.S. - Strategy, SWOT and Corporate Finance Report Summary Aselsan Elektronik Sanayi Ve Ticaret A.S. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SW …
  • BioCardia Inc:製品パイプライン分析
    Summary BioCardia Inc (BioCardia) is a clinical-stage regenerative medicine company that develops novel therapeutics for cardiovascular diseases. The company develops biotherapeutic candidate, which include CardiAMP cell therapy system, an autologous minimally processed bone marrow cells; and CardiA …
  • Leonardo DRS Inc:企業の戦略的SWOT分析
    Leonardo DRS Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • Housing Development Finance Corporation Ltd:企業のM&A・事業提携・投資動向
    Housing Development Finance Corporation Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Housing Development Finance Corporation Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, det …
  • Electrica SA (EL):電力:M&Aディール及び事業提携情報
    Summary Electrica SA (Electrica) is a power utility that distributes and supplies electricity. Its services include electricity supply, distribution, and trading, and power distribution networks operations and management, and design and consultation for aerial and subterranean power networks. It als …
  • St. Barbara Limited:企業の戦略・SWOT・財務情報
    St. Barbara Limited - Strategy, SWOT and Corporate Finance Report Summary St. Barbara Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Cheung Kong Infrastructure Holdings Ltd:企業の戦略・SWOT・財務分析
    Cheung Kong Infrastructure Holdings Ltd - Strategy, SWOT and Corporate Finance Report Summary Cheung Kong Infrastructure Holdings Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT a …
  • Raley’s Family of Fine Stores:企業の戦略的SWOT分析
    Raley's Family of Fine Stores - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produ …
  • Tactile Systems Technology Inc (TCMD):製品パイプライン分析
    Summary Tactile Systems Technology Inc (Tactile Medical) is a medical technology company that develops, manufactures and distributes medical devices for the treatment of chronic vascular diseases in a home setting. The company’s products are based on a unique, scalable platform. It offers products f …
  • Paliburg Holdings Limited:戦略・SWOT・企業財務分析
    Paliburg Holdings Limited - Strategy, SWOT and Corporate Finance Report Summary Paliburg Holdings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Yes Bank Ltd:企業の戦略・SWOT・財務分析
    Yes Bank Ltd - Strategy, SWOT and Corporate Finance Report Summary Yes Bank Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Greentech Energy Systems AS (GES)-エネルギー分野:企業M&A・提携分析
    Summary Greentech Energy Systems AS (Greentech) is an energy company which operates renewable energy plants. It generates electricity from wind and solar sources. Through long-term power purchase agreements, the company sells electricity. Greentech expands its asset portfolio through inorganic growt …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆